Reports world wide Market Spotlight Small-Cell Lung Cancer | Page 2

Pfizer has carried out the most Phase III trials in small cell lung cancer, with 8 trials,
followed by GlaxoSmithKline and BristolMyers Squibb which have each sponsored 6 Phase
III trials.
Report Contents
KEY TAKEAWAYS
DISEASE BACKGROUND
TREATMENT
Chemotherapy
Radiotherapy
Surgery
Palliative procedures
EPIDEMIOLOGY
PIPELINE DRUGS
MARKETED DRUGS
Approvals by country
KEY UPCOMING EVENTS
LICENSING AND ASSET ACQUISITION DEALS
PARENT PATENTS
REVENUE OPPORTUNITY
CLINICAL TRIAL LANDSCAPE
Sponsors by status
Sponsors by phase
OncoMed Trying To Regroup After Cancer Stem Cell Pipeline Failures
BIBLIOGRAPHY
Prescription Information:
APPENDIX
Ask to Expertise @
https://www.reportsworldwide.com/enquiry?report_id=42320
LIST OF FIGURES
Figure
Figure
Figure
Figure
Figure
1:
2:
3:
4:
5:
Trends in Incident Cases of Small Cell Lung Cancer, 2016–25
Pipeline drugs for SCLC in the US
Pipeline drugs for SCLC, by company
Pipeline drugs for SCLC, by drug type
Pipeline drugs for SCLC, by classification